← Open Payments lookup

ROBERT DUPREY: Open Payments

NPI 1225312168 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$280 in 14 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $478 · 2025 $280

Food & beverage: $280
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$97
ABBVIE INC.4$67
Otsuka America Pharmaceutical, Inc.2$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Teva Pharmaceuticals USA, Inc.1$19
Janssen Pharmaceuticals, Inc1$17
Alkermes, Inc.1$16

Products named: INGREZZA, VRAYLAR, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, SPRAVATO, LYBALVI.

Industry payments across WA — which companies pay providers there.